Esperion Therapeutics, Inc.
Pharmaceutical Preparations · 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI 48108
官方登记数据
0位关注者
2008成立于
关于 Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Source: Wikipedia
行业Pharmaceutical Preparations
总部3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI 48108
成立2008
法律形式C Corporation
状态营业中
专利194 项专利
METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAMEUS20260146017A1 · 2026
COMPOSITIONS CONTAINING, AND COMBINATION THERAPIES USING BEMPEDOIC ACID AND A GLP-1 RECEPTOR AGONISTEP4739301A1 · 2026
关键数据
法律信息
| 法定名称 | Esperion Therapeutics, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1434868在 SEC EDGAR 上查看 ↗ |
| 行业代码(SIC) | 2834 |
| 注册地址 | 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI 48108 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI 48108
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面